Cognivia
Cognivia improves clinical trial performance by quantifying patient psychology to reduce data variability and increase trial success rates. The company delivers a B2B SaaS platform that uses machine learning and data modeling to predict patient behavior, placebo response, heterogeneity, and dropout risk. Core products include Placebell™ and Compl-AI™, which characterize and manage individual placebo responses and improve assay sensitivity. Cognivia primarily serves biopharmaceutical companies and CROs and integrates clinical trial analytics into development workflows. Founded in 2013, the company targets faster, more confident go/no-go decisions and fewer required patients per study through up to 30% variability reduction.
Cognivia
Cognivia improves clinical trial performance by quantifying patient psychology to reduce data variability and increase trial success rates. The company delivers a B2B SaaS platform that uses machine learning and data modeling to predict patient behavior, placebo response, heterogeneity, and dropout risk. Core products include Placebell™ and Compl-AI™, which characterize and manage individual placebo responses and improve assay sensitivity. Cognivia primarily serves biopharmaceutical companies and CROs and integrates clinical trial analytics into development workflows. Founded in 2013, the company targets faster, more confident go/no-go decisions and fewer required patients per study through up to 30% variability reduction.